Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin vs Lifestyle Modification in PCOS
NCT06479434Completed
- Sponsor
- Aga Khan University
- Start
- Jun 2024
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of metformin in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Aga Khan University. Primary endpoint: Change in hormonal profile and menstrual cycle at 8 weeks. Started Jun 2024; status: completed.
02
Drugs
metformin
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06479434.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06479434.